Daniel P. Petrylak - Clinical Trials in MIBC and NMIBC

15 Views
Published
Daniel P. Petrylak, MD, leads the genitourinary cancers medical oncology team at Smilow Cancer Hospital as Director of the genitourinary cancer research group, Professor, and co-Director of the Cancer Signaling Network program at Yale Cancer Center, New Haven, Connecticut. In this 10-minute talk, he discusses advancements in treating urothelial carcinoma, emphasizing innovative therapies for BCG-refractory, recurrent, and metastatic disease.
Category
Oncology
Be the first to comment